S100A9 and systemic sclerosis: SSc epidermal explants release increased levels of S100A9, which was shown to induce fibroblast proliferation via TLR4, suggesting that the SSc epidermis provides an important source of proinflammatory S100A9 in SSc skin and, therefore, contributes to the inflammation seen in the disease [8].